Multimodal therapies in ductal pancreatic cancer
- 1 February 1997
- journal article
- review article
- Published by Springer Nature in International journal of pancreatology
- Vol. 21 (1) , 71-83
- https://doi.org/10.1007/bf02785923
Abstract
Conclusions. Intra-arterial infusion chemotherapy via the celiac axis combined with external beam radiotherapy might be an effective method for palliative and perioperative multimodal treatment in pancreatic cancer. To improve the dismal prognosis in resectable and nonresectable pancreatic cancer, the results of multimodal palliative, adjuvant, and neoadjuvant therapies were reviewed and put into perspective with the results of two intra-arterial palliative and adjuvant treatment studies conducted at our department. The benefits and pitfalls of each method were outweighted, resulting in a concept for performing intra-arterial chemotherapy with radiotherapy in nonresectable stage UICC-III pancreatic cancer that eventually will be developed as a combined neoadjuvant/adjuvant treatment of all potentially resectable ductal pancreatic carcinomas.Keywords
This publication has 63 references indexed in Scilit:
- Circadian rhythm-modulated chemotherapy with high-dose 5-fluorouracil: a pilot study in patients with pancreatic adenocarcinomaEuropean Journal Of Cancer, 1993
- Activity of cisplatin in adenocarcinoma of the pancreasEuropean Journal Of Cancer, 1993
- High-dose folinic acid, 5-fluorouracil bolus and infusion in advanced pancreatic adenocarcinoma: a pilot studyEuropean Journal Of Cancer, 1993
- Adjuvant combination chemotherapy (AMF) following radical resection of carcinoma of the pancreas and papilla of vater—results of a controlled, prospective, randomised multicentre studyEuropean Journal Of Cancer, 1993
- A phase II study of 5-fluorouracil, leucovorin and interferon-α in advanced pancreatic cancerAnti-Cancer Drugs, 1993
- Phase II trial with ifosfamide in pancreatic cancerEuropean Journal Of Cancer, 1993
- Epirubicin, etoposide and cisplatin in advanced pancreatic carcinomaEuropean Journal Of Cancer, 1993
- High-dose local irradiation plus prophylactic hepatic irradiation and chemotherapy for inoperable adenocarcinoma of the pancreas. A preliminary report of a multi-institutional trial (radiation therapy oncology group protocol 8801)Cancer, 1992
- A randomized controlled trial of adjuvant immunotherapy (murine monoclonal antibody 494/32) in resectable pancreatic cancerCancer, 1991
- Patterns of failure after curative resection of pancreatic carcinomaCancer, 1990